Skip to main content

Table 2 Overview of samples >25 units in the SmD1 (amino acids 83–119) ELISA

From: Effect of dsDNA binding to SmD-derived peptides on clinical accuracy in the diagnosis of systemic lupus erythematosus

Sample ID Diagnosis SmD3 (U/ml) SmD1 (U/ml)
25413 SLE 2.8 27.50
25414 SLE 3.9 29.40
25415 SLE 2.9 26.40
25419 SLE 8.9 91.70
25423 SLE 3.7 32.50
25427 SLE 26.2 200
25429 SLE 2.4 40.6
25431 SLE 2.0 27.2
25433 SLE 179.0 200
25434 SLE 3.4 26.4
25435 SLE 6.5 41.7
25437 SLE 2.6 64.7
25441 SLE 40.4 200
25442 SLE 3.0 37.8
25443 SLE 3.8 51.9
25444 SLE 4.3 59.6
25449 SLE 4.0 78.1
25450 SLE 18.5 200
25458 SLE 7.1 79.4
25459 SLE 6.1 29.6
25461 SLE 17.0 171.0
25514 SLE 529 200
25469 RA 0.1 31.7
25470 RA 7.3 70.8
25475 RA 0.0 32.0
25479 RA 0.1 37.7
25494 RA 2.4 28.7
25495 RA 1.2 29.7
25501 RA 2.4 51.1
25510 RA 3.4 29.2
25513 PM/Scl 3.1 43.8
25516 MCTD 3.8 32.3
25517 PM/Scl 1.3 94.9
25528 Scl 3.3 30.5
25529 Overlap syndrome 4.1 63.4
25530 Overlap syndrome 7.2 57.4
25536 Scl 3.2 80.3
25537 MCTD 3.5 29.7
25539 MCTD 1.5 26.6
25540 MCTD 4.5 33.5
25544 Overlap syndrome 8.8 99.7
25552 Overlap syndrome 3.4 32.2
25553 PM/Scl 9.6 41.4
25556 MCTD 2.8 34.3
  1. Data in bold show positive samples in the SmD3 ELISA. MCTD = mixed connective tissue disease; PM/Scl = polymyositis scleroderma overlap syndrome; RA = rheumatoid arthritis; Scl = scleroderma; SLE = systemic lupus erythematosus